Lennar Corporation (LEN)
Mexican Exchange · Mexico · prices in MXN · close of 22 Oct 2026
Key indicators
| Last close | MXN 1,560.00 |
|---|---|
| 52-week range | 1,310.00 – 2,413.69 |
| Return, 1 month / 3 months | +15.6% / +9.0% |
| Return, 1 year / 3 years | −34.5% / −18.8% |
| Trend | Below its 200-day average |
| RSI (14) | 67 |
| Volatility (1 year) | 35.1% |
| Worst drawdown (1 year) | -45.7% |
| Average daily value traded | 0.09M MXN |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lennar Corporation is a homebuilder based in Miami, Florida, that designs, builds and sells single-family homes, townhomes and condominiums. Its communities serve first-time buyers, move-up buyers and active-adult households across many regions of the United States. Alongside homebuilding, the company offers mortgage financing, title and insurance services to homebuyers through its financial services operations, and it also develops land for its own residential communities.
The shares are listed on the Mexican Exchange in Mexico under the code LEN, and the price on this page is in Mexican pesos (MXN). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lennar Corporation (LEN) trades on the Mexican Exchange in Mexico. It last closed at MXN 1,560.00 on 22 October 2026.
Its price-based Market X-Ray is 25 out of 100 (a weak price profile), ranking 325 of 361 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 34.5% and over the last three months it rose 9.0%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Mexican Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 16 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -3.5% | ||
| From 52-week high | -35.4% | ||
| Momentum | 39 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 9.0% | ||
| 6-month return | 3.0% | ||
| 12-month return, skipping the last month | -43.3% | ||
| Stability (higher is calmer) | 24 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -45.7% | ||
| Liquidity | 21 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.09M MXN | ||
| Zero-volume days | 55.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +9.9% |
|---|---|
| 1 month | +15.6% |
| 3 months | +9.0% |
| 6 months | +3.0% |
| 1 year | −34.5% |
| 3 years | −18.8% |
| 5 years | −19.5% |
Signals
| 50-day / 200-day average | 1,414.46 / 1,616.60 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 37.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Oct 2019 | MXN 0.0400 |
| 10 Jul 2019 | MXN 0.0400 |
| 23 Apr 2019 | MXN 0.0400 |
| 24 Jan 2019 | MXN 0.0400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Mexican Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.